Hospital
Rolling Plains Memorial Hospital
Rolling Plains Memorial Hospital was paid $711K by Medicaid between Nov 2020 and Nov 2024, across 39 billing codes. Its largest line is 99283, emergency room visit (moderate) — 48% of everything it billed.
33Billing provider infoROLLING PLAINS MEMORIAL HOSPITAL
SWEETWATER, TX 79556
SWEETWATER, TX 79556
33aNPI1275581852assigned 05/05/2006
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$711K
24GClaims26,710
24DCodes billed39
24AFirst – last monthNov 2020 – Nov 2024
Compared with peers
Next to other Medicare Defined Swing Bed Hospital Unit providers in Texas
Rank by total paid#5 of 6
Median peer was paid$983K
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 543 | $24K | |
| 2021 | 7,833 | $208K | |
| 2022 | 8,710 | $297K | |
| 2023 | 5,700 | $115K | |
| 2024incomplete | 3,924 | $67K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 48% | 1,398 | 1,361 | $343K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 12% | 969 | 949 | $85K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.8% | 150 | 140 | $48K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.6% | 348 | 320 | $47K |
| 87430 | 6.1% | 2,036 | 1,954 | $43K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.6% | 1,062 | 1,035 | $25K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.2% | 388 | 321 | $23K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.8% | 1,015 | 944 | $20K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 201 | 190 | $14K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.6% | 90 | 89 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.5% | 418 | 363 | $10K |
| 86756 | <1% | 356 | 342 | $7K |
27 more codes
| 81002 | <1% | 1,674 | $6K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,844 | $5K |
| 80053 | Comprehensive metabolic panel | <1% | 2,572 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,354 | $3K |
| 71045 | Radiologic examination, chest; single view | <1% | 112 | $3K |
| 87631 | <1% | 25 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 904 | $3K |
| 81001 | <1% | 1,607 | $1K | |
| 87186 | <1% | 773 | $902.74 | |
| 84439 | <1% | 618 | $853.20 | |
| 0240U | <1% | 15 | $800.28 | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 13 | $791.19 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 290 | $542.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 883 | $418.11 |
| 84484 | <1% | 138 | $247.10 | |
| 80061 | Lipid panel | <1% | 658 | $189.47 |
| 83880 | <1% | 42 | $107.58 | |
| 83735 | <1% | 110 | $43.32 | |
| 82550 | <1% | 13 | $22.98 | |
| 85730 | <1% | 13 | $17.18 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,417 | $12.84 |
| 85610 | <1% | 13 | $12.25 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 76 | $0.00 |
| 82746 | 0% | 13 | $0.00 | |
| 82607 | 0% | 13 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 12 | $0.00 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 77 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDIPPEL, DOUGLAS (CEO)